Full-Time
Technical Consultant
Patient Monitoring
Philips
Healthcare technology for diagnosis, care, wellness
Compensation Overview
$39 - $61/hr
No H1B Sponsorship
Syracuse, NY, USA
In Person
Must reside in or within commuting distance to Syracuse, New York.
Bachelor's, Associate's
 IT & Security (1) |
|---|
- Five or more years of professional working experience in information technology services or related technical environments; experience working in a hospital or clinical information technology environment is required; experience with patient monitoring, telemetry units, ventilators, and defibrillators is highly preferred.
- Advanced knowledge of computer networking, system integration, and technical troubleshooting in a healthcare information technology environment.
- Active Cisco Certified Network Associate certification is required; higher-level Cisco certifications such as Cisco Certified Network Professional are acceptable.
- An associate degree in computer science, biomedical engineering, or related field, or an equivalent combination of education and experience; a bachelor's degree is preferred.
- Ability to travel for business; approximately 75% travel across the specified geography is required; average driving time 1-4 hours daily; occasional overnight stays and travel by air/train may be required.
- Ability to work in an office/home office and/or remote setting, as well as in a hospital/healthcare environment; adhere to vendor credentialing requirements.
- Ability to work flexible hours, including non-standard work hours, overtime, weekends, and on-call rotations.
- Willingness to wear all required personal protective equipment.
- You are a technically strong and independent professional with a consultative approach to translating complex solutions, paired with strong communication, organizational rigor, and leadership skills that enable you to manage risk, influence others, and contribute to a collaborative, high-performing team environment.
- Independently lead and execute complex system installations, upgrades, and implementations across patient monitoring and IT infrastructure environments, ensuring reliable performance and high-quality delivery; provide hands-on troubleshooting, validation, and system optimization to maintain operational continuity.
- Serve as the primary technical authority for system architecture, networking decisions, configuration validation, and risk management; diagnose and resolve complex system and performance issues using advanced troubleshooting techniques and structured problem-solving approaches.
- Engage customers as a trusted advisor to understand technical environments, workflows, and operational challenges; lead technical discussions and deliver tailored recommendations that align solutions with clinical, business, and strategic objectives.
- Own configuration management, version control, and system validation while developing and promoting standardized methodologies and best practices; ensure consistency, scalability, and compliance while contributing to continuous improvement and organizational knowledge sharing.
- Collaborate cross-functionally with sales, clinical, service, and project teams while mentoring junior consultants to build technical capability and consistency; represent the organization professionally, strengthening customer relationships and supporting long-term success and growth.
- Higher-level Cisco certifications such as Cisco Certified Network Professional are acceptable in lieu of Cisco Certified Network Associate.
- Bachelor's degree is preferred.
- Experience with patient monitoring, telemetry units, ventilators, and defibrillators is preferred.
Philips develops health technology across professional medical devices, connected care, and consumer health products. Its offerings include diagnostic imaging and image-guided therapy, patient monitoring and clinical informatics, and everyday wellness products like oral and personal care. The company increasingly delivers integrated solutions through a Healthcare-as-a-Service subscription model and long-term partnerships with hospitals and health systems. Its aim is to improve people’s health and well-being by making advanced health technology easier to access and integrate into care.
Company Size
N/A
Company Stage
IPO
Headquarters
Andover, Minnesota
Founded
1891
Simplify's Take
What believers are saying
- May 18, 2026 Stockholm selected Philips for hospital-at-home coverage across up to 15,000 patients annually.
- Q1 2026 sales grew 4%, and Philips reiterated 2026 guidance on May 13, 2026.
- 2025 free cash flow reached EUR 512 million, supporting investment and shareholder returns.
What critics are saying
- August 2026 MDL still holds 624 Philips CPAP cases, extending legal drag.
- January 19, 2026 settlement covers economics only; DOJ consent-decree talks still threaten Respironics.
- A Respironics compliance failure can block U.S. sleep-device sales and tarnish Philips brand.
What makes Philips unique
- June 4, 2026 WellSpan alliance makes Philips preferred vendor across CT, MR, X-ray, ultrasound, image-guided therapy.
- August 6, 2026 ecosystem partnerships connect Philips monitoring from hospital beds to homes.
- Philips combines diagnosis, connected care, and personal health across 64,317 employees at Q1 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Health Savings Account/Flexible Spending Account
Company News
The global remote patient monitoring market is expected to grow from $67.3 billion in 2026 to $117.9 billion by 2033, registering a CAGR of 8.3%. Growth is driven by rising chronic disease prevalence, expanding telehealth services and increasing demand for home-based healthcare solutions. Devices and hardware account for nearly 38% of market share, led by connected blood pressure monitors, glucometers and wearable health trackers. North America holds approximately 41% of the global market, supported by strong digital healthcare infrastructure and favourable reimbursement policies. Asia Pacific is emerging as the fastest-growing region, driven by healthcare digitisation, telemedicine expansion and rising smartphone penetration. Leading players include Philips Healthcare, Medtronic, GE HealthCare and Abbott Laboratories, focusing on AI integration and cloud connectivity to enhance remote care delivery.
<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US, subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024. The company’s previously announced 2023-2025 financial outlook remains unchanged, already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more
Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.
In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.
February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.